Assessment of adherence to pharmacotherapy by patients on hemodialysis treated at a university hospital

• Autor(a) principal: Araújo Diniz, Sávio Bruno
• Data de Publicação: 2024
• Outros Autores: Pereira do Nascimento, Felipe Cícero, Martins Benvindo, Mariana, Monte Moreira, Francisca Sueli, Meira Lima de Sousa, Regina, Barbosa Brito da Matta, Carolina
• Tipo de documento: Artigo
• Idioma: por; eng
• Título da fonte: Diversitas Journal
• Texto Completo: https://diversitasjournal.com.br/diversitas_journal/article/view/2697
• topic: Adesão ao Tratamento Farmacológico; Hemodiálise; Atenção Farmacêutica.

This study aimed to evaluate adherence to pharmacotherapy by patients on hemodialysis treated at a university hospital. This is a descriptive, cross-sectional, prospective study with a quantitative approach, which used sociodemographic and clinical data, the Mini Mental State Examination and the Brief Medication Questionnaire. Of the 43 patients included, there was a predominance of females (55.8%) aged over 50 years (53.5%), single marital status (41.9%), with family income of 1 to 3, 5 minimum wages (69.8%) and with more than 7 years of study (67.4%). The underlying diseases of undetermined etiology had the highest prevalence (18.6%). Among the participants, 53.5% had 1 to 3 comorbidities (3.7 ± 2.2) and had been on hemodialysis for less than 1 year (55.8%). Regarding the number of medications in use, there was a difference between the amount collected in the self-report (5.1 ± 2) and that obtained in the medical record (5.9 ± 2.4). Of these, 69.8% of the patients obtained a score compatible with low adherence according to the BMQ total score. In the “Regime” domain, 88.4% presented barriers. In the “Beliefs” domain, 27.9% scored and in the “Recall” domain, 93% obtained a score compatible with non-adherence. There was no statistically significant association between sociodemographic variables, however, there was a correlation between polypharmacy and non-adherence (p=0.027). The study enabled the identification of barriers to medication adherence by the population under study, as well as its sociodemographic profile.